Science · 1 views

New bioreactor turns stem cells into an immune-cell factory, producing 40 million human macrophages per week

Researchers at Hannover Medical School (MHH) have developed a method for the efficient production of human immune cells, such as macropha…

Source Phys.org AI Summary Updated April 23, 2026

Story intelligence Beta

Freshness Stale Updated April 23, 2026

Confidence Limited Single-outlet story

Coverage Single outlet

Views 1 Community interest

Read time 1 min ~59 words

AI Summary

Researchers at Hannover Medical School (MHH) have developed a method for the efficient production of human immune cells, such as macrophages, in medium-sized bioreactors. These immune cells can be derived from induced pluripotent stem cells and are important for disease research and the development of new therapeutic approaches. The method has now been published in the journal Nature Protocols.

Read full article on PHYS

AI summaries can be wrong sometimes—always verify important details using the source article.

SUPPORT HAPPENINGNOW · Independent AI News Intelligence

SUPPORTER MESSAGE

Enjoyed this article? Consider supporting HappeningNow to help keep independent AI-powered news analysis moving forward. Your contribution helps cover infrastructure, AI summaries, and continued platform development.

Support HappeningNow